MSF Field Research > 1 Published Research and Commentary > TB > Response to antiretroviral therapy: improved survival associated with CD4 above 500 cells/μl.

Please use this identifier to cite or link to this item:     LinkedIn     Citeulike     Connotea     Facebook     Stumble it!

Download this article:
View/Open File Description Size Format
531_Maman_surv_500CD4_AIDS_12.pdf104KbAdobe PDF

Title: Response to antiretroviral therapy: improved survival associated with CD4 above 500 cells/μl.
Authors: Maman, David
Pujades-Rodriguez, Mar
Nicholas, Sarala
McGuire, Megan
Szumilin, Elisabeth
Ecochard, René
Etard, Jean-François
Affiliation: Epicentre, 8 rue saint Sabin, Paris, France; bHospices Civils de Lyon, Service de Biostatistique, cUniversite´ de Lyon, Lyon, France; Me´decins Sans Frontie`res, Paris, France.
Citation: AIDS 2012; 26(11): 1393-8.
Journal: AIDS (London, England)
Issue Date: 17-Jul-2012
DOI: 10.1097/QAD.0b013e328352d054
PubMed ID: 22441247
Additional Links:
Abstract: We investigated the association between immune response and mortality in four HIV African programs supported by Médecins Sans Frontières.
Type: Article
Language: en
Keywords: HIV/AIDS
ISSN: 1473-5571
Rights: Published by Wolters Kluwer Lippincott Williams & Wilkins - Archived on this site by kind permission Wolters Kluwer
Appears in topics: TB

Related articles on PubMed
Body mass index and early CD4 T-cell recovery among adults initiating antiretroviral therapy in North America, 1998-2010.
Koethe JR, Jenkins CA, Lau B, Shepherd BE, Silverberg MJ, Brown TT, Blashill AJ, Anema A, Willig A, Stinnette S, Napravnik S, Gill J, Crane HM, Sterling TR, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)
2015 May 11
See all 90 articles

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.


OR Logo Powered by Open Repository | Cookies


MSF logo MSF Field Research

Jul 4, 2015